NCT04441710View on ClinicalTrials.gov

Caregiver Serological Monitoring Extended Secondarily to Patients With the SARS-CoV-2 Coronavirus

CompletedOBSERVATIONAL

Enrollment

2,777

Participants

Timeline

Start Date

October 27, 2020

Primary Completion Date

December 16, 2022

Study Completion Date

December 16, 2022

Conditions

COVID

Interventions

OTHER

Questionnaire

Participants will be invited to complete a detailed questionnaire to collect prospectively and retrospectively data around the CoViD19 serological screening.

Trial Locations (4)

Unknown

CHU de Grenoble - Hôpital Nord, La Tronche

Hôpital de la Croix Rousse, Lyon

CHU de Saint Etienne, Saint-Etienne

Hôpital Henry Gabrielle, Saint-Genis-Laval

All Listed Sponsors

lead

Hospices Civils de Lyon

OTHER

NCT04441710 - Caregiver Serological Monitoring Extended Secondarily to Patients With the SARS-CoV-2 Coronavirus | Biotech Hunter | Biotech Hunter